Region
22 September 2017
Cardihab nudges investors for $1.35m
Multi-university venturing fund Uniseed has invested $500,000 in smartphone cardiac monitoring developer Cardihab.
Cardihab, an Australia-based patient management platform aimed at sufferers from a cardiac arrest, has spun out from research institute Commonwealth Scientific and Industrial Research Organisation (Csiro) with $1.35m in funding from investors including venture fund Uniseed.
Uniseed supplied $500,000 for the round, which also included…Read More.
21 September 2017
Disarm persuades investors for series A
Disarm Therapeutics, a US-based biotechnology developer focused on neurological diseases, raised $30m in a series A round on Tuesday from investors including AbbVie Ventures, the investment arm of…
20 September 2017
Immunocore takes in up to $40m
Charitable foundation Bill & Melinda Gates Foundation agreed yesterday to invest up to $40m in Immunocore, the UK-based biological drug developer spun out of biotech company MediGene in 2008.
Immunocore…
- 20 September 2017 – IP Group secures 96.5% of Touchstone support
- 20 September 2017 – LifeMine hatches $55m series A
- 20 September 2017 – Matroid meets Intel in $10m round
- 20 September 2017 – Ovensa scores $1.38m in capital
- 20 September 2017 – Numaferm pockets seed funding
